Samer Choucair: T2S IPO Confirms Morocco’s Capital Market Has Entered a New Phase of Investment Maturity
Entrepreneur Samer Choucair said the initial public offering of medical technology specialist T2S Group Holding represents a significant milestone in the development of Morocco’s capital markets after attracting more than 111,000 subscribers, making it the fifth-largest offering by number of participants in the history of the Casablanca Stock Exchange.
He emphasized that the transaction confirms the continuation of strong investment momentum in the Moroccan market despite prevailing economic and regional challenges.
Choucair explained that the offering, valued at approximately MAD 1.1 billion, or around $120 million, combined a MAD 350 million capital increase with the sale of MAD 750 million in existing shares at MAD 223 per share.
He said the transaction reflects growing investor confidence in companies operating across medical technology and healthcare.
Choucair added that total subscription orders reached MAD 48.1 billion, resulting in coverage of more than 43 times in the Casablanca Stock Exchange’s first listing of 2026.
He noted that this demonstrates the Moroccan market’s increasing ability to absorb high-quality offerings associated with the new economy.
Record demand reflects changes in the Moroccan market
Samer Choucair said the participation of investors from 81 nationalities illustrates the widening base of investors interested in the Moroccan market.
He explained that the strong demand was not attributable solely to the appeal of T2S, but also reflected increasing confidence in the Casablanca Stock Exchange’s ability to attract companies with business models centred on innovation and sustainable growth.
Choucair added that medical technology is receiving increasing attention from institutional investors as demand for healthcare services grows and digital transformation accelerates across Africa.
He emphasized that the strong demand for the company’s shares provides clear evidence of the Moroccan market’s increasing maturity and its ability to direct long-term capital toward sectors connected to healthcare infrastructure and technology.
Morocco’s economy supports a new wave of listings
Samer Choucair explained that the Moroccan economy is currently benefiting from the restoration of its investment-grade credit rating, alongside forecasts of economic growth approaching 5% during 2026, supported by substantial infrastructure investment ahead of the 2030 World Cup.
He added that the Casablanca Stock Exchange is implementing an ambitious strategy to increase the number of listed companies from approximately 80 today to 300 by 2035 by encouraging more industrial and technology businesses to enter the market.
Choucair noted that the T2S listing follows a series of successful offerings during 2025, including Vicenne, Cash Plus, and SGTM, all of which achieved strong subscription coverage and broad participation from individual investors.
He emphasized that retail investors have become an important force in revitalizing the Moroccan market, reshaping capital-allocation mechanisms and creating opportunities for more companies in defensive sectors, particularly healthcare, to pursue listings.
Medical technology leads the growth cycle
Samer Choucair explained that T2S Group, founded in 1992, has become Morocco’s largest medical technology company, operating in more than 20 African countries.
Its solutions include medical-imaging equipment, oncology treatment, laboratory diagnostics, and artificial intelligence-powered software.
Choucair added that the group generated revenue of MAD 1.76 billion during 2025, with recurring revenue accounting for 46% of the total, and is targeting revenue of MAD 4.17 billion by 2030.
He noted that part of the offering proceeds will be used to expand domestic manufacturing capabilities, develop hospital systems, and accelerate growth across African markets.
Choucair emphasized that this strategy reflects a broader regional movement toward localizing medical supply chains in North Africa, supported by higher government healthcare spending and growing demand for sustainable medical solutions.
Institutional investors reassess frontier markets
Samer Choucair said strong demand from institutional investors, despite retail investors representing the largest proportion of subscribers by number, reflects growing recognition of the attractiveness of the company’s business model.
He explained that T2S combines structural growth, recurring revenue, and direct exposure to African markets—a relatively rare combination capable of attracting regional and international investment funds.
Choucair added that offerings of this kind encourage investment institutions to reconsider the weighting of frontier markets within their portfolios, particularly markets exposed to demographic transformation and expanding healthcare expenditure across Africa.
He noted that the company’s post-listing success will remain dependent on governance quality and management’s ability to execute its expansion plans without a substantial increase in operating costs.
Capital flows move toward defensive sectors
Samer Choucair explained that the success of the T2S offering reflects a broader change in capital flows across the Arab and African regions.
He added that Gulf investors are increasingly seeking opportunities beyond traditional markets, while the Casablanca Stock Exchange provides Moroccan companies with a more efficient and lower-cost financing platform than international markets.
Choucair emphasized that capital-allocation strategies are becoming increasingly focused on sectors combining demographic demand with technological innovation, whether in Saudi Arabia under the objectives of Vision 2030 or in Morocco under its industrial and healthcare strategies.
He noted that successful offerings such as T2S reinforce this trend and support the movement of capital toward sectors with long-term growth potential.
Opportunities and risks for investors
Samer Choucair identified the continuing expansion of medical technology, rising healthcare expenditure, and the accelerating digital transformation of African health systems as the principal investment opportunities.
He added that Morocco also has an opportunity to benefit from the Casablanca Stock Exchange’s growing role as a regional corporate-financing centre.
However, Choucair noted that investors continue to face several risks, including currency volatility, the possibility of slower government spending, and intensifying competition from global medical-equipment companies.
He added that the allocation rate of approximately 2.3% demonstrates the difficulty new investors faced in securing substantial positions during the initial offering because of exceptionally strong demand.
A future outlook
Concluding his remarks, Samer Choucair said the Casablanca Stock Exchange is entering a new phase of institutional maturity, supported by stronger confidence among domestic and international investors, continuing economic reforms, and a growing number of high-quality listings.
He added that if current trends continue, 2026 is likely to bring further listings from companies operating in healthcare, technology, and financial services, strengthening Morocco’s position as a regional centre for investment and financing.
Choucair emphasized that the T2S listing represents more than a successful capital-raising exercise. It demonstrates the ability of Maghreb markets to attract long-term capital toward companies whose business models address the essential needs of the African continent.
“The success of future offerings will depend not only on the strength of demand, but also on the quality of the listed companies, governance transparency, and their ability to deliver sustainable growth that creates long-term value for investors,” Samer Choucair concluded.